INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,000 | -75.0% | 3,900 | -78.7% | 0.00% | -100.0% |
| Q4 2016 | $24,000 | +166.7% | 18,300 | +161.4% | 0.00% | – |
| Q3 2016 | $9,000 | +80.0% | 7,000 | +89.2% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 3,700 | +12.1% | 0.00% | – |
| Q1 2016 | $6,000 | -14.3% | 3,300 | -37.7% | 0.00% | – |
| Q4 2015 | $7,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 67,727 | $106,000 | 0.01% |
| Argent Trust Co | 15,121 | $23,000 | 0.01% |
| Acrospire Investment Management LLC | 3,700 | $6,000 | 0.00% |
| IFP Advisors, Inc | 13 | $0 | 0.00% |
| Advisor Group, Inc. | 5,255 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,756 | $21,000 | 0.00% |
| Citadel Advisors | 14,492 | $22,000 | 0.00% |
| Parallax Volatility Advisers, L.P. | 50,000 | $78,000 | 0.00% |
| Cutler Group LLC / CA | 3,700 | $5,000 | 0.00% |
| MORGAN STANLEY | 59,400 | $92,000 | 0.00% |